Patent ID: 8647659
Filing Date: 2014-02-11
Classification: A61K,A61L,A61P

Abstract:
1. A method for treating elevated intraocular pressure in an eye comprising the steps of: providing at least two biodegradable sustained release intracameral implants, each implant containing at least one prostamide; implanting the at least two biodegradable sustained release implants into the anterior chamber of the eye; and treating the elevated intraocular pressure, wherein each of the at least two biodegradable sustained release implants releases about 100 ng per day to about 900 ng per day of the at least one prostamide over the lifetime of the implant, and wherein the at least two biodegradable sustained release implants each comprise about 5% to about 40% of the least one prostamide, about 10% to about 60% R203S, which is a poly(D,L-lactide) having an inherent viscosity of about 0.25 to about 0.35 dl/g, about 5% to about 20% R202H, which is a poly(D,L-lactide) having an inherent viscosity of about 0.16 to about 0.24 dl/g, about 5% to about 40% RG752S, which is a poly(D,L-lactide-co-glycolide) having a D,L-lactide:glycolide molar ratio of about 73:27 to about 77:23 and an inherent viscosity of about 0.16 to about 0.24 dl/g, and about 5% to about 15% polyethylene glycol (PEG) 3350.